144 related articles for article (PubMed ID: 10195619)
41. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
43. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
44. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
45. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
46. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
47. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
48. Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.
Caselli E; Grandi P; Argnani R; Balboni PG; Selvatici R; Manservigi R
Intervirology; 2001; 44(1):1-7. PubMed ID: 11223713
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
50. Gene vaccination with naked plasmid DNA: mechanism of CTL priming.
Corr M; Lee DJ; Carson DA; Tighe H
J Exp Med; 1996 Oct; 184(4):1555-60. PubMed ID: 8879229
[TBL] [Abstract][Full Text] [Related]
51. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
52. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
[TBL] [Abstract][Full Text] [Related]
53. Targeted delivery of mitochondria to the liver in rats.
Liu X; Khouri-Farah N; Wu CH; Wu GY
J Gastroenterol Hepatol; 2020 Dec; 35(12):2241-2247. PubMed ID: 32386240
[TBL] [Abstract][Full Text] [Related]
54. Influence of antigen on immune complex behavior in mice.
Finbloom DS; Magilavy DB; Harford JB; Rifai A; Plotz PH
J Clin Invest; 1981 Jul; 68(1):214-24. PubMed ID: 6166633
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.
Witmer LA; Rosenthal KL; Graham FL; Friedman HM; Yee A; Johnson DC
J Gen Virol; 1990 Feb; 71 ( Pt 2)():387-96. PubMed ID: 2155292
[TBL] [Abstract][Full Text] [Related]
56. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236
[TBL] [Abstract][Full Text] [Related]
57. Preparation of asialoorosomucoid-polylysine conjugates.
McKee TD; DeRome ME; Wu GY; Findeis MA
Bioconjug Chem; 1994; 5(4):306-11. PubMed ID: 7948096
[TBL] [Abstract][Full Text] [Related]
58. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a needle-free delivery platform for prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus 2 glycoprotein D.
Meseda CA; Stout RR; Weir JP
Viral Immunol; 2006; 19(2):250-9. PubMed ID: 16817767
[TBL] [Abstract][Full Text] [Related]
60. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
Drew MD; Estrada AE; Underdown BJ; McDermott MR
Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
